Industry Research Reports
Home > Reports > Medical Devices & Consumables > Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 102 Pages
Report ld: 3481694
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Uterine Polyp Forceps Market Size(US$)
CAGR 2025-2031
3.1%
Market Size,2031
USD 19.7
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 16.4 million
Market Forecast in 2031(Value)
US$ 19.7 million
CAGR
3.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Uterine Polyp Forceps was estimated to be worth US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Uterine polyp forceps is a medical device used in gynecological treatment to remove polyps in the uterus. Uterine polyps are benign tumors located on the surface of the endometrium, usually due to excessive proliferation of endometrial tissue. Although uterine polyps are generally benign, they can cause menstrual abnormalities, infertility, or other gynecological problems, so they often require treatment or removal.
This report aims to provide a comprehensive presentation of the global market for Uterine Polyp Forceps, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Uterine Polyp Forceps by region & country, by Type, and by Application.
The Uterine Polyp Forceps market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Polyp Forceps.
MARKET SEGMENTATION
By Company
- CooperSurgical
- DTR Medical
- Integra LifeSciences
- Vernacare
- Surtex Instruments
- Sklar Corporation
- Bolton Surgical
- BR Surgical
- BD
- Surgical Holdings
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Straight
- Curved
Segment by Application
- Hospitals
- Clinics
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Uterine Polyp Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Uterine Polyp Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Uterine Polyp Forceps in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Uterine Polyp Forceps Product Introduction
1.2 Global Uterine Polyp Forceps Market Size Forecast
1.2.1 Global Uterine Polyp Forceps Sales Value (2020-2031)
1.2.2 Global Uterine Polyp Forceps Sales Volume (2020-2031)
1.2.3 Global Uterine Polyp Forceps Sales Price (2020-2031)
1.3 Uterine Polyp Forceps Market Trends & Drivers
1.3.1 Uterine Polyp Forceps Industry Trends
1.3.2 Uterine Polyp Forceps Market Drivers & Opportunity
1.3.3 Uterine Polyp Forceps Market Challenges
1.3.4 Uterine Polyp Forceps Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Uterine Polyp Forceps Players Revenue Ranking (2024)
2.2 Global Uterine Polyp Forceps Revenue by Company (2020-2025)
2.3 Global Uterine Polyp Forceps Players Sales Volume Ranking (2024)
2.4 Global Uterine Polyp Forceps Sales Volume by Company Players (2020-2025)
2.5 Global Uterine Polyp Forceps Average Price by Company (2020-2025)
2.6 Key Manufacturers Uterine Polyp Forceps Manufacturing Base and Headquarters
2.7 Key Manufacturers Uterine Polyp Forceps Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Uterine Polyp Forceps
2.9 Uterine Polyp Forceps Market Competitive Analysis
2.9.1 Uterine Polyp Forceps Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Uterine Polyp Forceps Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Polyp Forceps as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Straight
3.1.2 Curved
3.2 Global Uterine Polyp Forceps Sales Value by Type
3.2.1 Global Uterine Polyp Forceps Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Uterine Polyp Forceps Sales Value, by Type (2020-2031)
3.2.3 Global Uterine Polyp Forceps Sales Value, by Type (%) (2020-2031)
3.3 Global Uterine Polyp Forceps Sales Volume by Type
3.3.1 Global Uterine Polyp Forceps Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Uterine Polyp Forceps Sales Volume, by Type (2020-2031)
3.3.3 Global Uterine Polyp Forceps Sales Volume, by Type (%) (2020-2031)
3.4 Global Uterine Polyp Forceps Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Uterine Polyp Forceps Sales Value by Application
4.2.1 Global Uterine Polyp Forceps Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Uterine Polyp Forceps Sales Value, by Application (2020-2031)
4.2.3 Global Uterine Polyp Forceps Sales Value, by Application (%) (2020-2031)
4.3 Global Uterine Polyp Forceps Sales Volume by Application
4.3.1 Global Uterine Polyp Forceps Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Uterine Polyp Forceps Sales Volume, by Application (2020-2031)
4.3.3 Global Uterine Polyp Forceps Sales Volume, by Application (%) (2020-2031)
4.4 Global Uterine Polyp Forceps Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Uterine Polyp Forceps Sales Value by Region
5.1.1 Global Uterine Polyp Forceps Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Uterine Polyp Forceps Sales Value by Region (2020-2025)
5.1.3 Global Uterine Polyp Forceps Sales Value by Region (2026-2031)
5.1.4 Global Uterine Polyp Forceps Sales Value by Region (%), (2020-2031)
5.2 Global Uterine Polyp Forceps Sales Volume by Region
5.2.1 Global Uterine Polyp Forceps Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Uterine Polyp Forceps Sales Volume by Region (2020-2025)
5.2.3 Global Uterine Polyp Forceps Sales Volume by Region (2026-2031)
5.2.4 Global Uterine Polyp Forceps Sales Volume by Region (%), (2020-2031)
5.3 Global Uterine Polyp Forceps Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Uterine Polyp Forceps Sales Value, 2020-2031
5.4.2 North America Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Uterine Polyp Forceps Sales Value, 2020-2031
5.5.2 Europe Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Uterine Polyp Forceps Sales Value, 2020-2031
5.6.2 Asia Pacific Uterine Polyp Forceps Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Uterine Polyp Forceps Sales Value, 2020-2031
5.7.2 South America Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Uterine Polyp Forceps Sales Value, 2020-2031
5.8.2 Middle East & Africa Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Uterine Polyp Forceps Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Uterine Polyp Forceps Sales Value
6.2.1 Key Countries/Regions Uterine Polyp Forceps Sales Value, 2020-2031
6.2.2 Key Countries/Regions Uterine Polyp Forceps Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Uterine Polyp Forceps Sales Value, 2020-2031
6.3.2 United States Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Uterine Polyp Forceps Sales Value, 2020-2031
6.4.2 Europe Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Uterine Polyp Forceps Sales Value, 2020-2031
6.5.2 China Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.5.3 China Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Uterine Polyp Forceps Sales Value, 2020-2031
6.6.2 Japan Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Uterine Polyp Forceps Sales Value, 2020-2031
6.7.2 South Korea Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Uterine Polyp Forceps Sales Value, 2020-2031
6.8.2 Southeast Asia Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Uterine Polyp Forceps Sales Value, 2020-2031
6.9.2 India Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
6.9.3 India Uterine Polyp Forceps Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 CooperSurgical
7.1.1 CooperSurgical Company Information
7.1.2 CooperSurgical Introduction and Business Overview
7.1.3 CooperSurgical Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 CooperSurgical Uterine Polyp Forceps Product Offerings
7.1.5 CooperSurgical Recent Development
7.2 DTR Medical
7.2.1 DTR Medical Company Information
7.2.2 DTR Medical Introduction and Business Overview
7.2.3 DTR Medical Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 DTR Medical Uterine Polyp Forceps Product Offerings
7.2.5 DTR Medical Recent Development
7.3 Integra LifeSciences
7.3.1 Integra LifeSciences Company Information
7.3.2 Integra LifeSciences Introduction and Business Overview
7.3.3 Integra LifeSciences Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Integra LifeSciences Uterine Polyp Forceps Product Offerings
7.3.5 Integra LifeSciences Recent Development
7.4 Vernacare
7.4.1 Vernacare Company Information
7.4.2 Vernacare Introduction and Business Overview
7.4.3 Vernacare Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Vernacare Uterine Polyp Forceps Product Offerings
7.4.5 Vernacare Recent Development
7.5 Surtex Instruments
7.5.1 Surtex Instruments Company Information
7.5.2 Surtex Instruments Introduction and Business Overview
7.5.3 Surtex Instruments Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Surtex Instruments Uterine Polyp Forceps Product Offerings
7.5.5 Surtex Instruments Recent Development
7.6 Sklar Corporation
7.6.1 Sklar Corporation Company Information
7.6.2 Sklar Corporation Introduction and Business Overview
7.6.3 Sklar Corporation Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Sklar Corporation Uterine Polyp Forceps Product Offerings
7.6.5 Sklar Corporation Recent Development
7.7 Bolton Surgical
7.7.1 Bolton Surgical Company Information
7.7.2 Bolton Surgical Introduction and Business Overview
7.7.3 Bolton Surgical Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bolton Surgical Uterine Polyp Forceps Product Offerings
7.7.5 Bolton Surgical Recent Development
7.8 BR Surgical
7.8.1 BR Surgical Company Information
7.8.2 BR Surgical Introduction and Business Overview
7.8.3 BR Surgical Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 BR Surgical Uterine Polyp Forceps Product Offerings
7.8.5 BR Surgical Recent Development
7.9 BD
7.9.1 BD Company Information
7.9.2 BD Introduction and Business Overview
7.9.3 BD Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 BD Uterine Polyp Forceps Product Offerings
7.9.5 BD Recent Development
7.10 Surgical Holdings
7.10.1 Surgical Holdings Company Information
7.10.2 Surgical Holdings Introduction and Business Overview
7.10.3 Surgical Holdings Uterine Polyp Forceps Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Surgical Holdings Uterine Polyp Forceps Product Offerings
7.10.5 Surgical Holdings Recent Development
8 Industry Chain Analysis
8.1 Uterine Polyp Forceps Industrial Chain
8.2 Uterine Polyp Forceps Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Uterine Polyp Forceps Sales Model
8.5.2 Sales Channel
8.5.3 Uterine Polyp Forceps Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Uterine Polyp Forceps Market Trends
Table 2. Uterine Polyp Forceps Market Drivers & Opportunity
Table 3. Uterine Polyp Forceps Market Challenges
Table 4. Uterine Polyp Forceps Market Restraints
Table 5. Global Uterine Polyp Forceps Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Uterine Polyp Forceps Revenue Market Share by Company (2020-2025)
Table 7. Global Uterine Polyp Forceps Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Uterine Polyp Forceps Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Uterine Polyp Forceps Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Uterine Polyp Forceps Manufacturing Base and Headquarters
Table 11. Key Manufacturers Uterine Polyp Forceps Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Uterine Polyp Forceps
Table 13. Global Uterine Polyp Forceps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Polyp Forceps as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Uterine Polyp Forceps Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Uterine Polyp Forceps Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Uterine Polyp Forceps Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Uterine Polyp Forceps Sales Market Share in Value by Type (2020-2025)
Table 20. Global Uterine Polyp Forceps Sales Market Share in Value by Type (2026-2031)
Table 21. Global Uterine Polyp Forceps Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Uterine Polyp Forceps Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Uterine Polyp Forceps Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Uterine Polyp Forceps Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Uterine Polyp Forceps Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Uterine Polyp Forceps Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Uterine Polyp Forceps Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Uterine Polyp Forceps Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Uterine Polyp Forceps Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Uterine Polyp Forceps Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Uterine Polyp Forceps Sales Market Share in Value by Application (2020-2025)
Table 32. Global Uterine Polyp Forceps Sales Market Share in Value by Application (2026-2031)
Table 33. Global Uterine Polyp Forceps Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Uterine Polyp Forceps Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Uterine Polyp Forceps Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Uterine Polyp Forceps Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Uterine Polyp Forceps Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Uterine Polyp Forceps Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Uterine Polyp Forceps Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Uterine Polyp Forceps Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Uterine Polyp Forceps Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Uterine Polyp Forceps Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Uterine Polyp Forceps Sales Value by Region (2020-2025) & (%)
Table 44. Global Uterine Polyp Forceps Sales Value by Region (2026-2031) & (%)
Table 45. Global Uterine Polyp Forceps Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Uterine Polyp Forceps Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Uterine Polyp Forceps Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Uterine Polyp Forceps Sales Volume by Region (2020-2025) & (%)
Table 49. Global Uterine Polyp Forceps Sales Volume by Region (2026-2031) & (%)
Table 50. Global Uterine Polyp Forceps Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Uterine Polyp Forceps Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Uterine Polyp Forceps Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Uterine Polyp Forceps Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Uterine Polyp Forceps Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Uterine Polyp Forceps Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Uterine Polyp Forceps Sales Volume, (2026-2031) & (K Units)
Table 57. CooperSurgical Company Information
Table 58. CooperSurgical Introduction and Business Overview
Table 59. CooperSurgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. CooperSurgical Uterine Polyp Forceps Product Offerings
Table 61. CooperSurgical Recent Development
Table 62. DTR Medical Company Information
Table 63. DTR Medical Introduction and Business Overview
Table 64. DTR Medical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. DTR Medical Uterine Polyp Forceps Product Offerings
Table 66. DTR Medical Recent Development
Table 67. Integra LifeSciences Company Information
Table 68. Integra LifeSciences Introduction and Business Overview
Table 69. Integra LifeSciences Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Integra LifeSciences Uterine Polyp Forceps Product Offerings
Table 71. Integra LifeSciences Recent Development
Table 72. Vernacare Company Information
Table 73. Vernacare Introduction and Business Overview
Table 74. Vernacare Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Vernacare Uterine Polyp Forceps Product Offerings
Table 76. Vernacare Recent Development
Table 77. Surtex Instruments Company Information
Table 78. Surtex Instruments Introduction and Business Overview
Table 79. Surtex Instruments Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Surtex Instruments Uterine Polyp Forceps Product Offerings
Table 81. Surtex Instruments Recent Development
Table 82. Sklar Corporation Company Information
Table 83. Sklar Corporation Introduction and Business Overview
Table 84. Sklar Corporation Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sklar Corporation Uterine Polyp Forceps Product Offerings
Table 86. Sklar Corporation Recent Development
Table 87. Bolton Surgical Company Information
Table 88. Bolton Surgical Introduction and Business Overview
Table 89. Bolton Surgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Bolton Surgical Uterine Polyp Forceps Product Offerings
Table 91. Bolton Surgical Recent Development
Table 92. BR Surgical Company Information
Table 93. BR Surgical Introduction and Business Overview
Table 94. BR Surgical Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. BR Surgical Uterine Polyp Forceps Product Offerings
Table 96. BR Surgical Recent Development
Table 97. BD Company Information
Table 98. BD Introduction and Business Overview
Table 99. BD Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. BD Uterine Polyp Forceps Product Offerings
Table 101. BD Recent Development
Table 102. Surgical Holdings Company Information
Table 103. Surgical Holdings Introduction and Business Overview
Table 104. Surgical Holdings Uterine Polyp Forceps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Surgical Holdings Uterine Polyp Forceps Product Offerings
Table 106. Surgical Holdings Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Uterine Polyp Forceps Downstream Customers
Table 110. Uterine Polyp Forceps Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Uterine Polyp Forceps Product Picture
Figure 2. Global Uterine Polyp Forceps Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Uterine Polyp Forceps Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Uterine Polyp Forceps Sales Volume (2020-2031) & (K Units)
Figure 5. Global Uterine Polyp Forceps Sales Price (2020-2031) & (US$/Unit)
Figure 6. Uterine Polyp Forceps Report Years Considered
Figure 7. Global Uterine Polyp Forceps Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Uterine Polyp Forceps Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Uterine Polyp Forceps Revenue in 2024
Figure 10. Uterine Polyp Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Straight Picture
Figure 12. Curved Picture
Figure 13. Global Uterine Polyp Forceps Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Uterine Polyp Forceps Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Uterine Polyp Forceps Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Uterine Polyp Forceps Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Uterine Polyp Forceps Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Clinics
Figure 20. Global Uterine Polyp Forceps Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Uterine Polyp Forceps Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Uterine Polyp Forceps Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 23. Global Uterine Polyp Forceps Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Uterine Polyp Forceps Price by Application (2020-2031) & (US$/Unit)
Figure 25. North America Uterine Polyp Forceps Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Uterine Polyp Forceps Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Uterine Polyp Forceps Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Uterine Polyp Forceps Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Uterine Polyp Forceps Sales Volume (%), (2020-2031)
Figure 37. United States Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 43. China Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 45. China Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 55. India Uterine Polyp Forceps Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Uterine Polyp Forceps Sales Value by Type (%), 2024 VS 2031
Figure 57. India Uterine Polyp Forceps Sales Value by Application (%), 2024 VS 2031
Figure 58. Uterine Polyp Forceps Industrial Chain
Figure 59. Uterine Polyp Forceps Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Uterine Polyp Forceps in 2031?
The global market size of Uterine Polyp Forceps in 2031 was 19.7 Million USD.
Which companies rank high in the global Uterine Polyp Forceps market?
What was the global market size of Uterine Polyp Forceps in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Uterine Polyp Forceps market size from 2025 to 2031?
Related Reports
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2026
The global Uterine Polyp Forceps market was valued at US$ 16.38 million in 2025 and is anticipated to reach US$ 20.22 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 116
USD 2900.00
(Single User License)
Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Uterine Polyp Forceps market is projected to grow from US$ 15.9 million in 2024 to US$ 19.7 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 81
USD 2900.00
(Single User License)
Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published Date: 2024-01-10
Pages: 123
USD 3950.00
(Single User License)
Uterine Polyp Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Uterine Polyp Forceps was estimated to be worth US$ 16.38 million in 2025 and is projected to reach US$ 20.22 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
USD 3950.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2026
The global Uterine Polyp Forceps market was valued at US$ 16.38 million in 2025 and is anticipated to reach US$ 20.22 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 116
USD 2900.00 (Single User License)Global Uterine Polyp Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Uterine Polyp Forceps market size was US$ 15.9 million in 2024 and is forecast to a readjusted size of US$ 19.7 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)Global Uterine Polyp Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Uterine Polyp Forceps market is projected to grow from US$ 15.9 million in 2024 to US$ 19.7 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
USD 4900.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2025
The global market for Uterine Polyp Forceps was valued at US$ 15.9 million in the year 2024 and is projected to reach a revised size of US$ 19.7 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 81
USD 2900.00 (Single User License)Global Uterine Polyp Forceps Market Insights, Forecast to 2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-04-12
Pages: 105
USD 4900.00 (Single User License)Global Uterine Polyp Forceps Market Research Report 2024
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)Uterine Polyp Forceps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Uterine Polyp Forceps are commonly used for the removal of polyps from the uterus. The forceps feature hollow clamps with fenestrated jaws to firmly grasp the polyp to be removed. The ring handles allow for comfortable and secure grip of the instrument.
Published: 2024-01-10
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now